By Jeff Rose
Zacks upgraded shares of Alphatec Holdings (NASDAQ:ATEC) from a sell rating to a hold rating in a research
note issued to investors on Tuesday, MarketBeat reports.
According to Zacks, “Alphatec Holdings, Inc. is a medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders. The Company’s principal product offering includes a variety of spinal implant products and systems consisted of components, such as spine screws and rods, spinal spacers, plates, and various biologics offerings. Alphatec Holdings, Inc. is headquartered in Carlsbad, California. “
Separately, Canaccord Genuity lowered shares of Alphatec Holdings from a buy rating to a hold rating and cut their price objective for the company from $2.50 to $1.00 in a research report on Wednesday, August 5th. They noted that the move was a valuation call.
